6 pending office actions • 0 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (17%) |
| §102 only | 2 (33%) |
| §112 only | 2 (33%) |
| Multi-statute (no §101) | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCHMIDT, IZABELA MARIA | 1 | 66.0% | +44.5% |
| MAHLUM, JONATHAN DAVIS | 1 | 51.4% | +20.5% |
| RAO, SAVITHA M | 1 | 60.7% | +30.2% |
| LEESER, ERICH A | 1 | 81.7% | +13.4% |
| CORNET, JEAN P | 1 | 42.1% | +47.5% |
| VALLE, ERNESTO | 1 | 56.7% | +37.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18755178 | Synthetic Cannabinoid Compounds, Pharmaceutical Compositions, and Treatment Methods | LEESER, ERICH A | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19034034 | Synthetic Cannabigerol Quinone Analogs and Pharmaceutical Compositions Containing Same for Treating Neurological Disorders | SCHMIDT, IZABELA MARIA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19034034 | Synthetic Cannabigerol Quinone Analogs and Pharmaceutical Compositions Containing Same for Treating Neurological Disorders | SCHMIDT, IZABELA MARIA | — |
| 18891706 | ANTIBACTERIAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF TREATING BACTERIAL INFECTIONS | MAHLUM, JONATHAN DAVIS | — |
| 18832143 | Anticancer Compounds, Pharmaceutical Compositions, and Methods of Treating Cancers | RAO, SAVITHA M | — |
| 18755178 | Synthetic Cannabinoid Compounds, Pharmaceutical Compositions, and Treatment Methods | LEESER, ERICH A | — |
| 18721001 | Anti-inflammatory Compounds, Pharmaceutical Compositions, and Treatment Methods | CORNET, JEAN P | — |
| 18673060 | Anxiolytic Compounds, Pharmaceutical Compositions, and Methods of Treating Anxiety and Other Disorders | VALLE, ERNESTO | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19034034 | Synthetic Cannabigerol Quinone Analogs and Pharmaceutical Compositions Containing Same for Treating Neurological Disorders | SCHMIDT, IZABELA MARIA | — | §103§112 | Non-Final OA | — | Pending | Jan 22, 2025 |
| 18891706 | ANTIBACTERIAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF TREATING BACTERIAL INFECTIONS | MAHLUM, JONATHAN DAVIS | — | §112 | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18832143 | Anticancer Compounds, Pharmaceutical Compositions, and Methods of Treating Cancers | RAO, SAVITHA M | — | §102Other | Non-Final OA | — | Pending | Jul 23, 2024 |
| 18755178 | Synthetic Cannabinoid Compounds, Pharmaceutical Compositions, and Treatment Methods | LEESER, ERICH A | — | §103 | Non-Final OA | — | Pending | Jun 26, 2024 |
| 18721001 | Anti-inflammatory Compounds, Pharmaceutical Compositions, and Treatment Methods | CORNET, JEAN P | — | §112 | Non-Final OA | — | Pending | Jun 17, 2024 |
| 18673060 | Anxiolytic Compounds, Pharmaceutical Compositions, and Methods of Treating Anxiety and Other Disorders | VALLE, ERNESTO | — | §102 | Non-Final OA | — | Pending | May 23, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial